Bright Minds Biosciences is a biotechnology company. Co. is creating chemical entities as targeted therapeutic agents for treatment of disorders where a serotonin (5-HT) receptor (either 5-HT2A, 5-HT2C or 5-HT2A/C) driven mechanism is the underlying pathology. These targeted neurocircuit disorders include neuropsychiatric, neurodegenerative, neuroinflammatory and pain disorders. Examples of these diseases include 5-HT2C disorders like pediatric epilepsies, Alzheimer's disease psychosis and dementia, 5-HT2A receptor disorders like depression and post-traumatic stress disorder, and 5-HT2A/C neuropathic pain syndromes including cluster headaches and chemotherapy induced peripheral neuropathy. We show 1 historical shares outstanding datapoints in our DRUG shares outstanding history coverage, used to compute DRUG market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing DRUG market cap history over the course of time is important for investors
interested in comparing DRUG's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of DRUG versus a peer is one thing; comparing
DRUG market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like DRUG can fluctuate over the course of history.
With this page we aim to empower investors researching DRUG by allowing them to research the DRUG market cap history. |
Free DRUG Email Alerts:
Video: The Importance of Market Cap
